Cargando…
Cerebral Amyloid Positivity Prediction Models Using Clinical Data in Subjects With Mild Cognitive Impairment and Dementia
OBJECTIVE: Due to high cost of amyloid imaging, its use of amyloid imaging to confirm amyloid pathology is limited in clinical practice. It is of importance to develop a model to predict cerebral amyloid positivity using clinical data obtained from a memory clinic. METHODS: A total of 410 participan...
Autores principales: | Joo, Soo Hyun, Lee, Chang Uk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neuropsychiatric Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473862/ https://www.ncbi.nlm.nih.gov/pubmed/34500505 http://dx.doi.org/10.30773/pi.2021.0104 |
Ejemplares similares
-
PT586. Body Mass Index and Progression to Dementia in Patients with Mild Cognitive Impairment
por: Joo, Soo Hyun, et al.
Publicado: (2016) -
Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2017) -
Impact of Amyloid Pathology in Mild Cognitive Impairment Subjects: The Longitudinal Cognition and Surface Morphometry Data
por: Chang, Hsin-I, et al.
Publicado: (2022) -
Prediction of fast decline in amyloid positive mild cognitive impairment patients using multimodal biomarkers
por: Jang, Hyemin, et al.
Publicado: (2019) -
Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression
por: Wei, Hong-Chun, et al.
Publicado: (2021)